Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

324
Morre, D. JamesNOX Technologies
tNOX, ENOX, ENOX2, NXOB826, NX034
Other
Proteomics
Breast and Gynecologic Cancers Research

Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our derivation

To obtain preliminary indications of utility for serum detection of breast and ovarian cancer.
sandwich ELISA

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement